Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Daniel Raymond, MD, is a thoracic surgeon in the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified in general and thoracic surgery.
Specialty interests: Minimally invasive thoracic surgery, lung surgery, lung cancer, lung nodules, mediastinal surgery, chest wall surgery, esophageal surgery, surgical infectious disease, VATS lobectomy, and surgical quality.
Number of Procedures Performed: Dr. Raymond has performed more than 1,500 thoracic surgeries throughout his career, including more than 300 VATS lobectomy procedures.
Success rates: Cleveland Clinic thoracic surgeons perform more than 2,000 general thoracic procedures each year.to treat patients with a wide range of conditions, including lung, esophageal, chest wall, pleural, tracheal, mediastinal, foregut and diaphragm disease. Cleveland Clinic contributes to the Society of Thoracic Surgery Database in order to maintain the highest possible standards. Our 2013 outcomes include the lowest risk-adjusted mortality rate for lobectomy in the nation. Success rates for specific procedures are available at http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx
Education and Training: Dr. Raymond completed his undergraduate degree at the University of Pennsylvania, and earned his medical degree from the State University of New York Health Science Center, Syracuse. He completed a surgical residency, a research fellowship, and a surgical infectious disease fellowship at the University of Virginia Health Sciences Center, Charlottesville. Dr. Raymond completed his training with a fellowship in cardiothoracic surgery at the University of Pennsylvania Health System, Philadelphia.
Following his training, Dr. Raymond was an assistant professor of surgery in the Division of Thoracic and Foregut Surgery at the University of Rochester Medical Center, NY. He participated in several committees, including the Antibiotic Subcommittee, Quality Assurance Committee, Hospital Therapeutics Committee, and was the Compliance Officer for the Department of Surgery.
Dr. Raymond moved to Cleveland in 2011 to join the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. In addition to his clinical activities, he is the Quality Officer for thoracic surgery, the Co-Director of the Lung Cancer Tumor Board, and a member of the Cancer Executive Committee, Clinical Competency Committee, Surgical Quality Committee, Disaster Triage Officer, and Tracheostomy Committee.
Publications and Speaking: Dr. Raymond has more than 85 published articles and abstracts and twelve medical textbook chapters to his credit.
About Dr. Raymond: “I am honored to be a member of the Cleveland Clinic team dedicated to the multidisciplinary care of patients with thoracic disease, both benign and malignant. It is a pleasure to work with skilled and accomplished individuals who can provide compassionate and efficient care with unsurpassed quality. There is no greater satisfaction than the gratitude of a patient who has received world-class care.”
Leisure Activities: Dr. Raymond enjoys cooking, biking, hiking, swimming and traveling with his wife and two children. He also enjoys reading historical fiction, fly fishing and skiing.
Minimally invasive thoracic surgery, lung surgery, lung cancer, lung nodules, mediastinal surgery, chest wall surgery, esophageal surgery, surgical infectious disease, VATS lobectomy, and surgical quality. Minimally invasive thoracic surgery, Lung surgery, lung cancer, lung nodules, mediastinal surgery, chest wall surgery, esophageal surgery, surgical infectious disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/28/2014, Dr. Raymond has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.